Back to Results

Life Stem Genetics (LIFS)

Life Stem Genetics Inc. is a development-stage healthcare company whose common stock is listed on OTC Markets under the symbol LIFS. The company focuses on building stem cell therapy clinic operations with an emphasis on global expansion. Its described activities include stem cell banking, stem cell-based treatments for degenerative conditions, anti-aging applications, and therapies related to orthopedics, neurological disorders, and lung diseases. Life Stem Genetics also references additional offerings such as nutraceuticals, medical supplements, IV nutritional cocktails, hyperbaric oxygen therapy, cancer-related treatments, weight-loss services, and anti-viral therapy. The company was founded in 2012 and is based in East Stroudsburg, Pennsylvania. It also has a strategic collaborative agreement with American CryoStem Corporation.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-LIFS
—
—
—
—
—
—
Fair
—
—
—
0.0%
—
—
—
—
24.583 K
—
—
—
—
—
—
Valuation • Fair Value

Life Stem Genetics (OTC-LIFS) Fair Value by Valuation Model

Compare the primary fair value estimate for Life Stem Genetics (OTC-LIFS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

Not available

Data is currently unavailable.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Life Stem Genetics (OTC-LIFS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Life Stem Genetics (OTC-LIFS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

Not available

Data is currently unavailable.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Life Stem Genetics (OTC-LIFS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Life Stem Genetics (OTC-LIFS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

Not available

Data is currently unavailable.

Beneish M-Score

Not available

Data is currently unavailable.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

Not available

Data is currently unavailable.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Life Stem Genetics (OTC-LIFS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Life Stem Genetics (OTC-LIFS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Life Stem Genetics (OTC-LIFS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Life Stem Genetics (OTC-LIFS) Stock Forecast & Technical Outlook

Review Life Stem Genetics (OTC-LIFS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Life Stem Genetics (OTC-LIFS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Life Stem Genetics (OTC-LIFS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Life Stem Genetics (OTC-LIFS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Life Stem Genetics (OTC-LIFS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Life Stem Genetics (OTC-LIFS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Life Stem Genetics (OTC-LIFS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Life Stem Genetics (OTC-LIFS) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Life Stem Genetics (OTC-LIFS) Stock FAQ

Quick answers about Life Stem Genetics (OTC-LIFS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

A fair value estimate for Life Stem Genetics (OTC-LIFS) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

An analyst price target for Life Stem Genetics (OTC-LIFS) is not currently available in the latest data file.

The current financial health read for Life Stem Genetics (OTC-LIFS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current market capitalization listed for Life Stem Genetics is 24.583 K.

The ticker symbol for Life Stem Genetics is OTC-LIFS, and the stock is listed on OTC Markets.

Life Stem Genetics (OTC-LIFS) is listed on OTC Markets.

Similar Healthcare Providers & Services Stocks on OTC Markets View more

Fresenius SE & Co KGaA ADR (FSNUY) Fresenius SE & Co KGaA ADR (FSNUY)
Bangkok Dusit Medical Services PCL ADR (BDUUY) Bangkok Dusit Medical Services PCL ADR (BDUUY)
Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY)
Sonic Healthcare Ltd ADR (SKHHY) Sonic Healthcare Ltd ADR (SKHHY)
Ramsay Health Care Ltd ADR (RMYHY) Ramsay Health Care Ltd ADR (RMYHY)
SINOPHARM GROUP CO LTD ADR (SHTDY) SINOPHARM GROUP CO LTD ADR (SHTDY)
Bumrungrad Hospital PCL DRC (BUGDF) Bumrungrad Hospital PCL DRC (BUGDF)
Medipal Holdings Corp ADR (MAHLY) Medipal Holdings Corp ADR (MAHLY)
Extendicare Inc (EXETF) Extendicare Inc (EXETF)
Netcare Ltd ADR (NWKHY) Netcare Ltd ADR (NWKHY)
Ryman Healthcare Ltd ADR (RYHTY) Ryman Healthcare Ltd ADR (RYHTY)
Rhoen Klinikum AG ADR (RKAGY) Rhoen Klinikum AG ADR (RKAGY)
Life Healthcare Group Holdings (LTGHY) Life Healthcare Group Holdings (LTGHY)
Medical Facilities Corporation (MFCSF) Medical Facilities Corporation (MFCSF)
Healwell Al Inc (HWAIF) Healwell Al Inc (HWAIF)
Global Cord Blood Corp (CORBF) Global Cord Blood Corp (CORBF)
Kenilworth Systems C (GAMG) Kenilworth Systems C (GAMG)
Interpace Biosciences Inc (IDXG) Interpace Biosciences Inc (IDXG)
Elite Health Systems Inc (EHSI) Elite Health Systems Inc (EHSI)
Exlites Holdings International Inc (EXHI) Exlites Holdings International Inc (EXHI)
Psychemedics Corporation (PMDI) Psychemedics Corporation (PMDI)
Syra Health Corp (SYRA) Syra Health Corp (SYRA)
Cardiff Lexington Corp (CDIX) Cardiff Lexington Corp (CDIX)
Pacific Health Care Organization Inc (PFHO) Pacific Health Care Organization Inc (PFHO)